These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36813477)

  • 1. The prevention and management strategies for neonatal chronic lung disease.
    Harris C; Greenough A
    Expert Rev Respir Med; 2023 Feb; 17(2):143-154. PubMed ID: 36813477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal prevention of bronchopulmonary dysplasia.
    Greenough A; Ahmed N
    J Perinat Med; 2013 Jan; 41(1):119-26. PubMed ID: 23096098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Daoud P; Zupan V; Moreau F; Guilhoto I; Rouabah M; Alexandre C; Saliba E; Storme L; Patkai J; Pomedio M; Hamon I
    Acta Paediatr; 2018 Jul; 107(7):1140-1144. PubMed ID: 29193276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia.
    Heo M; Jeon GW
    Turk J Pediatr; 2020; 62(4):551-559. PubMed ID: 32779407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BPD treatments: The never-ending smorgasbord.
    Zayegh AM; Davis PG
    Semin Fetal Neonatal Med; 2021 Apr; 26(2):101223. PubMed ID: 33674252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence.
    Poets CF; Lorenz L
    Arch Dis Child Fetal Neonatal Ed; 2018 May; 103(3):F285-F291. PubMed ID: 29363502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in treating bronchopulmonary dysplasia.
    Williams E; Greenough A
    Expert Rev Respir Med; 2019 Aug; 13(8):727-735. PubMed ID: 31244360
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchopulmonary dysplasia.
    Deakins KM
    Respir Care; 2009 Sep; 54(9):1252-62. PubMed ID: 19712501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis.
    Tang W; Chen S; Shi D; Ai T; Zhang L; Huang Y; Fan Y; Du Y
    Pediatr Pulmonol; 2022 Feb; 57(2):455-469. PubMed ID: 34783192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
    Szabó H; Baraldi E; Colin AA
    Pediatr Pulmonol; 2022 Apr; 57(4):787-795. PubMed ID: 34964564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Concepts of Corticosteroids Use for the Prevention of Bronchopulmonary Dysplasia.
    Perrone S; Orlando S; Petrolini C; Marinelli F; Moretti S; Corradi M; Giordano M; De Bernardo G
    Curr Pediatr Rev; 2023; 19(3):276-284. PubMed ID: 36043724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From classic to new bronchopulmonary dysplasia].
    Kramer BW; Lievense S; Been JV; Zimmermann LJ
    Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.
    D'Angio CT; Maniscalco WM
    Paediatr Drugs; 2004; 6(5):303-30. PubMed ID: 15449969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.